JinkoSolar Holding Co., Ltd.
JKS is a deeply distressed solar leader priced for structural failure, and even a partial normalization in margins and shipment quality can support a sharp rebound from $10.68 despite very weak current fundamentals.
The market is pricing JKS like a broken capital structure attached to a commodity business, and that is not irrational. FY2025 revenue fell 52.3% to $9.8B, FY2025 EPS collapsed to -$50.85, and Q2 2026 EBITDA was -$1.42B with an -11.5% margin. Those are ugly numbers. But at $10.68, the market cap is just $0.1B, the stock trades at 0.02x sales and 0.07x book, and the shares are already 66.5% below the 52-week high and 51.4% below the 200-day average. That is not normal undervaluation. That is distress pricing.
The case depends on three things. First, management must prove that its new strategy is real: lower shipment volume, better order quality, better cash conversion. The key line on the call was explicit, "we will place greater emphasis on balancing shipment volume, profitability, cash flow and order quality going forward". That matters because JKS cannot win a pure scale war with $7.4B of debt and Debt/Equity 3.40. Second, margins must stop falling. Q2 gross margin fell to 4.2% from 8.3% in Q1, so the promised Q3 moderate improvement is not a nice-to-have, it is the thesis checkpoint. Third, the product mix has to earn a premium. High-efficiency products are guided to exceed 60% of FY2026 shipments, and TOPCon 3.0 capacity above 40 GW is one of the few levers that can improve economics without a major volume rebound.
What the market may be mispricing is the asymmetry. JKS does not need to become a high-return business to work from here. It only needs to show that cash losses are narrowing, that shipment discipline holds, and that overseas plus high-efficiency capacity still gives it a place in a harsher industry structure. Positive operating cash flow in Q2 and H1 is an important early sign.
What keeps conviction low is simple. This is still a company with negative earnings, heavy leverage, uneven guidance credibility, and 5 misses in the last 8 earnings reports. If Q3 margin improvement fails to show up, the stock can still go materially lower. The upside is large because the starting price is so depressed, but the path is narrow.
Module ASPs improve, high-efficiency mix exceeds 60%, ESS growth contributes, and short interest at 28.70% adds fuel to a sharp recovery trade.
Cash flow discipline works, Q3 and Q4 margins improve sequentially, and the market rerates the stock modestly from distressed 0.02x sales without requiring a full earnings recovery.
Margins fail to recover from 4.2% gross margin, shipment cuts deepen below 60 GW, and leverage at $7.4B debt forces the market to price in restructuring risk.
Quant call (BUY) diverges from analyst consensus (Hold: 0 buy / 2 hold / 0 sell) — resolve explicitly.
Never, ever invest in the present.
Forward earnings power is the entire debate because trailing earnings are unusable. At $10.68, the market is not valuing JKS on a normal forward P/E, it is valuing it on survival odds and whether shipment discipline can lift gross margin off Q2's 4.2% and EBITDA margin off -11.5%. The moat is narrower than it looked two years ago, but it is not gone: scale, overseas capacity of 14 GW, and high-efficiency TOPCon 3.0 capacity above 40 GW still matter, though returns will stay weak if solar remains a commodity price war. AI is mostly an indirect demand tailwind through data-center power needs, not a direct moat builder for JKS, while regulation is a bigger swing factor because trade barriers across the U.S., Europe, and India can both constrain addressable demand and reward local manufacturing footprints.
- Valuation is extreme at 0.02x P/S and 0.07x P/B, versus peer average 1.2x P/S, with the quant base target at $21.47, or 101.0% upside from $10.68.
- Management cut FY2026 module shipment guidance to 60-70 GW and is prioritizing profitability, cash flow, and order quality, while guiding moderate gross margin improvement in Q3 from Q2's 4.2%.
- Operating stress is real: FY2025 revenue was $9.8B, down 52.3% YoY, FY2025 operating margin was -3.3%, and Q2 2026 EBITDA was -$1.42B at an -11.5% margin.
- The stock is already priced for near-failure at $0.1B market cap against $9.8B FY2025 revenue, with P/S 0.02 and P/B 0.07, leaving room for outsized upside if losses narrow rather than disappear.
- Management is no longer defending volume at any price. The CEO said, "Considering demand dynamics in certain markets, we will place greater emphasis on balancing shipment volume, profitability, cash flow and order quality going forward", and Q2 operating cash flow turned positive as AR and inventory days improved.
- Product mix can still help. High-efficiency products are guided to exceed 60% of FY2026 shipments, TOPCon 3.0 capacity above 40 GW is planned by year-end, and management expects these products to benefit from China efficiency standards in 2027.
- Storage adds an offset. ESS shipments are still expected to more than double YoY in FY2026, and management says storage will use an asset-light model with JV structures, limiting near-term capital demands.
- Balance-sheet leverage is the core problem: Debt/Equity 3.40, Debt/EBITDA 240.46, and $7.4B of total debt leave little room for another prolonged pricing war.
- Operating performance is deteriorating, not just weak. Q2 2026 gross margin fell to 4.2% from 8.3% in Q1, and EBITDA margin worsened to -11.5% from -6.7% sequentially.
- Demand and pricing quality remain fragile. FY2026 shipment guidance was cut to 60-70 GW, well below the 100-110 GW full-year shipment target management gave back on the 2024 Q1 call for FY2024, underscoring a materially weaker industry setup.
- Execution credibility is mixed at best. JKS missed EPS estimates in 5 of the last 8 reported periods, including -237.3% on 2026-08-26 and -268.9% on 2026-03-25.
| Metric | Value | Context |
|---|---|---|
| Current price | $10.68 | Reference point for all upside and downside scenarios |
| Quant price target | $21.47 | 101.0% upside, Low confidence, basis: sales_quality_blend |
| FY2025 revenue | $9.8B | -52.3% YoY, severe contraction |
| FY2025 EPS | -$50.85 | -408.2% YoY, trailing earnings unusable for valuation |
| FY2025 operating margin | -3.3% | Slightly better than prior FY -3.6%, but still negative |
| Q2 2026 EBITDA margin | -11.5% | Down from -6.7% in Q1 and from 37.5% YoY |
| Valuation | 0.02x P/S, 0.07x P/B, P/E N/A | Versus peer avg 1.2x P/S and 12.8x P/E, though peers are weak comparables |
| Balance sheet leverage | Debt/Equity 3.40, Debt/EBITDA 240.46 | Highly stressed capital structure |
| Total debt | $7.4B | Primary financial risk given current profitability |
| FY2026 module shipment guide | 60-70 GW | Guidance cut, with focus shifting to profitability and cash flow |
| Short interest | 28.70% | 3,606,311 shares, 4.7 days-to-cover, up 37.9% |
| 52-week position | -66.5% vs high, -51.4% vs 200-day | Now near the $10.67-$31.88 range low |
The biggest risk is that gross margin stays near Q2's 4.2% or EBITDA margin stays near -11.5%, which would make $7.4B of debt and 3.40x debt/equity hard to carry through another downcycle year.
The next catalyst is the November 16, 2026 earnings report, where investors need to see the promised Q3 gross margin improvement and proof that lower-volume, higher-quality orders are stabilizing cash generation.
Positioning is volatile. Short interest is 28.70%, or 3,606,311 shares, up 37.9%, with 4.7 days-to-cover, which creates real squeeze potential if margins improve even modestly. Options positioning is also unstable, with a negative gamma regime and zero-gamma at $10.89, just 1.39% above spot, which can amplify moves in either direction around earnings. Institutional ownership is concentrated, with the top three institutions at 97.7%, but insider ownership at 0.0% offers little alignment signal.
Core business remains tied to module shipments, with FY2026 guidance cut to 60-70 GW as JKS shifts from scale to margin and cash flow.
Management expects FY2026 ESS shipments to more than double YoY, offering one of the few current growth offsets.
Trade barriers are rising across the U.S., Europe, and India, so overseas capacity of 14 GW by end-2026 matters strategically even if current geographic revenue data is unavailable.
Jinko cut full-year module shipment guidance as it prioritizes profitability and cash flow over volume.
Execution has slipped materially versus the 2024 Q1 playbook. Back then management guided 100-110 GW FY2024 module shipments, said Q2 gross margin would be "relatively stable" versus Q1's 11.9%, and highlighted net income of $84.4M with improving net debt. Today, FY2026 shipment guidance is just 60-70 GW, Q2 2026 gross margin is down to 4.2%, and Q2 2026 EBITDA margin is -11.5%. Management does deserve some credit for adapting rather than denying the new reality: it is now explicitly prioritizing cash flow and order quality, operating cash flow turned positive, and CapEx has been cut hard. Still, the earnings record is not that of a serial beater, with 5 misses in the last 8 reports, so credibility is mixed and conviction should stay low until margin recovery actually shows up in reported numbers.
Considering demand dynamics in certain markets, we will place greater emphasis on balancing shipment volume, profitability, cash flow and order quality going forward and adjusting guidance for full year 2026 module shipments to between 60 gigawatts and 70 gigawatts and high-efficiency products accounting for over 60%.
We expect our annual integrated production capacity to reach approximately 100 gigawatts by year-end 2026, including approximately 14 gigawatts from overseas facilities.
Leveraging our leading position and high-efficiency products, we optimized our sales mix during the quarter, resulting in gross margin reaching 4.2%, up 1.3 percentage points year-over-year.
We guided down the shipments, right, to 60 to 70. That's a clear message. And we don't believe it's the right time to focus on the scale and the profitability and the operating cash flow is the key.
We did expect gross margin moderate improvement in the third quarter.
JKS still has real industrial advantages in manufacturing scale, bankability, and high-efficiency product development. Planned year-end 100 GW integrated capacity, 14 GW overseas capacity, and >40 GW of TOPCon 3.0 capacity are meaningful assets. The problem is durability: in commodity solar, those advantages protect volume better than price, so the moat is only moderately durable unless technology leadership restores a sustained premium.
Capital allocation has turned defensive. Management said CapEx will stay very small for the next two years, storage will run on an asset-light model, and local manufacturing will use JV structures where possible. That is the right posture with FCF $0.0B, no buybacks, no dividend, and a heavily levered balance sheet, but it also confirms that balance-sheet repair has priority over growth spending.
JKS rates a BUY at Low conviction. The stock is washed out, the valuation is extreme, and even modest operational stabilization can produce a large percentage move higher from $10.68. This is not a quality story and not a balance-sheet-safe story, so position sizing matters. The view changes to more bullish only if Q3 confirms margin recovery and shipment discipline, and it changes to SELL if margins stay near Q2 levels and cash flow improvement fades.
≣ Full research note tap to expand
Executive Summary
BUY, Low conviction. Rated BUY, Low conviction. The stock has already collapsed 66.5% from its 52-week high to $10.68, trades at just 0.02x sales and 0.07x book, and management is explicitly shifting from volume chasing to cash flow and order quality. The counterpoint is severe: FY2025 revenue fell 52.3%, FY2025 EPS was -$50.85, Q2 2026 EBITDA margin was -11.5%, and execution has been erratic, so this is a balance-sheet-stressed turnaround trade, not a clean compounder.
Investment Thesis
The market is pricing JKS like a broken capital structure attached to a commodity business, and that is not irrational. FY2025 revenue fell 52.3% to $9.8B, FY2025 EPS collapsed to -$50.85, and Q2 2026 EBITDA was -$1.42B with an -11.5% margin. Those are ugly numbers. But at $10.68, the market cap is just $0.1B, the stock trades at 0.02x sales and 0.07x book, and the shares are already 66.5% below the 52-week high and 51.4% below the 200-day average. That is not normal undervaluation. That is distress pricing.
The case depends on three things. First, management must prove that its new strategy is real: lower shipment volume, better order quality, better cash conversion. The key line on the call was explicit, "we will place greater emphasis on balancing shipment volume, profitability, cash flow and order quality going forward". That matters because JKS cannot win a pure scale war with $7.4B of debt and Debt/Equity 3.40. Second, margins must stop falling. Q2 gross margin fell to 4.2% from 8.3% in Q1, so the promised Q3 moderate improvement is not a nice-to-have, it is the thesis checkpoint. Third, the product mix has to earn a premium. High-efficiency products are guided to exceed 60% of FY2026 shipments, and TOPCon 3.0 capacity above 40 GW is one of the few levers that can improve economics without a major volume rebound.
What the market may be mispricing is the asymmetry. JKS does not need to become a high-return business to work from here. It only needs to show that cash losses are narrowing, that shipment discipline holds, and that overseas plus high-efficiency capacity still gives it a place in a harsher industry structure. Positive operating cash flow in Q2 and H1 is an important early sign.
What keeps conviction low is simple. This is still a company with negative earnings, heavy leverage, uneven guidance credibility, and 5 misses in the last 8 earnings reports. If Q3 margin improvement fails to show up, the stock can still go materially lower. The upside is large because the starting price is so depressed, but the path is narrow.
Key Metrics
| Metric | Value | Context |
|---|---|---|
| Current price | $10.68 | Reference point for all upside and downside scenarios |
| Quant price target | $21.47 | 101.0% upside, Low confidence, basis: sales_quality_blend |
| FY2025 revenue | $9.8B | -52.3% YoY, severe contraction |
| FY2025 EPS | -$50.85 | -408.2% YoY, trailing earnings unusable for valuation |
| FY2025 operating margin | -3.3% | Slightly better than prior FY -3.6%, but still negative |
| Q2 2026 EBITDA margin | -11.5% | Down from -6.7% in Q1 and from 37.5% YoY |
| Valuation | 0.02x P/S, 0.07x P/B, P/E N/A | Versus peer avg 1.2x P/S and 12.8x P/E, though peers are weak comparables |
| Balance sheet leverage | Debt/Equity 3.40, Debt/EBITDA 240.46 | Highly stressed capital structure |
| Total debt | $7.4B | Primary financial risk given current profitability |
| FY2026 module shipment guide | 60-70 GW | Guidance cut, with focus shifting to profitability and cash flow |
| Short interest | 28.70% | 3,606,311 shares, 4.7 days-to-cover, up 37.9% |
| 52-week position | -66.5% vs high, -51.4% vs 200-day | Now near the $10.67-$31.88 range low |
Financial Strength
Financial strength is weak. Leverage is the central fact, not a side note: $7.4B of debt, 3.40x debt/equity, and 240.46x debt/EBITDA sit against a business that just posted -$50.85 of FY2025 EPS and -11.5% Q2 2026 EBITDA margin. The only encouraging counterweight is that operating cash flow turned positive in Q2 and H1 as working capital improved, which suggests management still has liquidity levers even in a bad market. Current ratio at 1.13 is serviceable, but not enough to make the balance sheet comfortable if pricing stays weak.
Competitive Position
JKS still has real industrial advantages in manufacturing scale, bankability, and high-efficiency product development. Planned year-end 100 GW integrated capacity, 14 GW overseas capacity, and >40 GW of TOPCon 3.0 capacity are meaningful assets. The problem is durability: in commodity solar, those advantages protect volume better than price, so the moat is only moderately durable unless technology leadership restores a sustained premium.
Management & Guidance
Management's latest guidance is a reset, not a growth plan. FY2026 module shipments were cut to 60-70 GW, high-efficiency mix is targeted at over 60%, integrated capacity at 100 GW by year-end, overseas capacity at 14 GW, and ESS shipments are expected to more than double YoY. The strategic logic is sensible because management is explicitly walking away from low-quality orders and low-price markets, and CapEx restraint is appropriate. Credibility is only moderate to low, though, because the company has missed EPS expectations in 5 of the last 8 reports and margins deteriorated sharply into Q2 before this reset.
Segment Analysis
- Solar modules and integrated PV products (Majority of revenue, exact FY2025 split not disclosed in provided data): Core business remains tied to module shipments, with FY2026 guidance cut to 60-70 GW as JKS shifts from scale to margin and cash flow.
- Energy storage systems (Minority of revenue, exact FY2025 split not disclosed in provided data): Management expects FY2026 ESS shipments to more than double YoY, offering one of the few current growth offsets.
- Overseas markets (Historical mix was >70% of Q1 2024 module shipments overseas): Trade barriers are rising across the U.S., Europe, and India, so overseas capacity of 14 GW by end-2026 matters strategically even if current geographic revenue data is unavailable.
Capital Allocation
Capital allocation has turned defensive. Management said CapEx will stay very small for the next two years, storage will run on an asset-light model, and local manufacturing will use JV structures where possible. That is the right posture with FCF $0.0B, no buybacks, no dividend, and a heavily levered balance sheet, but it also confirms that balance-sheet repair has priority over growth spending.
Management Execution & Track Record
Execution has slipped materially versus the 2024 Q1 playbook. Back then management guided 100-110 GW FY2024 module shipments, said Q2 gross margin would be "relatively stable" versus Q1's 11.9%, and highlighted net income of $84.4M with improving net debt. Today, FY2026 shipment guidance is just 60-70 GW, Q2 2026 gross margin is down to 4.2%, and Q2 2026 EBITDA margin is -11.5%. Management does deserve some credit for adapting rather than denying the new reality: it is now explicitly prioritizing cash flow and order quality, operating cash flow turned positive, and CapEx has been cut hard. Still, the earnings record is not that of a serial beater, with 5 misses in the last 8 reports, so credibility is mixed and conviction should stay low until margin recovery actually shows up in reported numbers.
Positioning & Flows
Positioning is volatile. Short interest is 28.70%, or 3,606,311 shares, up 37.9%, with 4.7 days-to-cover, which creates real squeeze potential if margins improve even modestly. Options positioning is also unstable, with a negative gamma regime and zero-gamma at $10.89, just 1.39% above spot, which can amplify moves in either direction around earnings. Institutional ownership is concentrated, with the top three institutions at 97.7%, but insider ownership at 0.0% offers little alignment signal.
Bull Case
- The stock is already priced for near-failure at $0.1B market cap against $9.8B FY2025 revenue, with P/S 0.02 and P/B 0.07, leaving room for outsized upside if losses narrow rather than disappear.
- Management is no longer defending volume at any price. The CEO said, "Considering demand dynamics in certain markets, we will place greater emphasis on balancing shipment volume, profitability, cash flow and order quality going forward", and Q2 operating cash flow turned positive as AR and inventory days improved.
- Product mix can still help. High-efficiency products are guided to exceed 60% of FY2026 shipments, TOPCon 3.0 capacity above 40 GW is planned by year-end, and management expects these products to benefit from China efficiency standards in 2027.
- Storage adds an offset. ESS shipments are still expected to more than double YoY in FY2026, and management says storage will use an asset-light model with JV structures, limiting near-term capital demands.
Bear Case
- Balance-sheet leverage is the core problem: Debt/Equity 3.40, Debt/EBITDA 240.46, and $7.4B of total debt leave little room for another prolonged pricing war.
- Operating performance is deteriorating, not just weak. Q2 2026 gross margin fell to 4.2% from 8.3% in Q1, and EBITDA margin worsened to -11.5% from -6.7% sequentially.
- Demand and pricing quality remain fragile. FY2026 shipment guidance was cut to 60-70 GW, well below the 100-110 GW full-year shipment target management gave back on the 2024 Q1 call for FY2024, underscoring a materially weaker industry setup.
- Execution credibility is mixed at best. JKS missed EPS estimates in 5 of the last 8 reported periods, including -237.3% on 2026-08-26 and -268.9% on 2026-03-25.
Valuation & Price Target
Engine price target $21.47 (+101% vs current), Low confidence.
- P/S Multiple: $740.72 (0% weight)
- Quality-adjusted: $8.71 (20% weight)
- DCF: $40547.76 (0% weight)
This rating stays with the quant baseline BUY, but with Low conviction for the same reason the engine flags Low confidence. The valuation case is obvious, with a $21.47 target, 101.0% upside, 0.02x P/S, and a stock down 66.5% from the high. The reason not to upgrade conviction is equally obvious: quality is just 27/100, risk is 63/100, FY2025 EPS was -$50.85, and leverage is extreme at $7.4B of debt and 3.40x debt/equity. Analyst consensus sits at Hold with only 2 firms, but that is low-signal context and does not outweigh the setup. The decision here is that the stock is cheap enough for a tactical BUY, but not healthy enough for anything stronger.
Risk Assessment
Risk score 63/100 (Moderate). The biggest risk is that gross margin stays near Q2's 4.2% or EBITDA margin stays near -11.5%, which would make $7.4B of debt and 3.40x debt/equity hard to carry through another downcycle year.
The Bottom Line
JKS rates a BUY at Low conviction. The stock is washed out, the valuation is extreme, and even modest operational stabilization can produce a large percentage move higher from $10.68. This is not a quality story and not a balance-sheet-safe story, so position sizing matters. The view changes to more bullish only if Q3 confirms margin recovery and shipment discipline, and it changes to SELL if margins stay near Q2 levels and cash flow improvement fades.
Go deeper in the app
Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.
Get Tickr